Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 11,050 CBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 11,050 | n/a |
| Jun 1, 2026 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 13,160 | n/a |
| Jun 23, 2025 | GLYCOMIMETICS INC (CBIO) | Grant/Award | 9,023 | n/a |
| Jun 18, 2025 | BioAtla, Inc. (BCAB) | Grant/Award | 23,500 | n/a |
| Jun 2, 2025 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 22,200 | n/a |
| Jun 14, 2024 | BioAtla, Inc. (BCAB) | Grant/Award | 16,500 | n/a |
| May 9, 2024 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 37,200 | n/a |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 323,455 | $20.22M |
| Feb 6, 2024 | RayzeBio, Inc. (RYZB) | Exercise/Conversion | 30,875 | $100.0K |
| Jun 15, 2023 | BioAtla, Inc. (BCAB) | Grant/Award | 50,000 | n/a |